NASDAQ:TYME Tyme Technologies (TYME) Stock Price, News & Analysis → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free TYME Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.29▼$0.3250-Day Range$0.24▼$0.3552-Week Range$0.22▼$1.14Volume2.68 million shsAverage Volume1.01 million shsMarket Capitalization$53.50 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Tyme Technologies alerts: Email Address Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. About Tyme Technologies Stock (NASDAQ:TYME)Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey.Read More Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. TYME Stock News HeadlinesMay 28 at 8:22 AM | apnews.comLuckily for cooks and gardeners, some herbs come back year after yearMay 28 at 8:22 AM | msn.comHow Thyme Can Boost Your Health: Nutrition Professionals Share Their InsightsMay 28 at 12:58 AM | msn.comAdding Apps To Board Games Is As Smart As It Is ControversialMay 28 at 12:58 AM | msn.comNYT Mini Crossword today: puzzle answers for Monday, May 27May 21, 2024 | msn.comTymeBank, running on AWS, proves fully digital banking is profitable, transformativeMay 16, 2024 | msn.comSuperbooth 2024 live: all the latest synth news from Berlin, as it happensMay 9, 2024 | msn.comThe Best TV Channels You Can Stream for FreeMay 2, 2024 | msn.comStudents visit Schott Glass after participating in contestMay 2, 2024 | finance.yahoo.comThyme Care Recruits Palliative Care Physician from Mount Sinai to Launch Enhanced Supportive Care ServicesMay 1, 2024 | yahoo.com49 Awesome Pizza Puns & Jokes That Can't Be ToppedMay 1, 2024 | finance.yahoo.comSCENTAIR® EXPANDS ITS PRODUCT LINE TO INCLUDE CANDLES AND AUTO FRAGRANCES FOR UNITED KINGDOM CUSTOMERSApril 30, 2024 | msn.com42 Cleaning Tips from People Who Always Have a Spotless HomeApril 29, 2024 | msn.comMax to Add 78 New Titles In May - Here's the 3 Most InterestingApril 29, 2024 | bloomberg.comUnicorns-Backed Norrsken22 Bets on Africa’s Fintech BoomApril 27, 2024 | msn.comHow to Get More From Your Air FryerApril 27, 2024 | msn.comTo Frost Cakes In Seconds, Try This Microwave HackApril 24, 2024 | msn.comThis time management app works across all your Apple devices and will make planning your days a piece of cakeApril 19, 2024 | yahoo.com50 Mother’s Day Gifts on Amazon She'll Never Guess You Bought Last-MinuteApril 16, 2024 | yahoo.comTop teen chef: SST student and Vino e Vivo cook Orion Raczek wins big SkillsUSA contestApril 16, 2024 | msn.comIqaluit's Toonik Tyme wraps up with race to Kimmirut and backApril 13, 2024 | msn.comThyme Companion Planting Guide [What to Plant with Thyme]April 3, 2024 | ca.news.yahoo.comHow your tax returns could be affected by CRA's bare trust debacleApril 2, 2024 | msn.com25 Pun-Tastic Creations From This Artist’s SketchpadApril 1, 2024 | msn.comNinja Foodi Beef StewMarch 23, 2024 | msn.com7 great Google Gemini AI prompts to try this weekendSee More Headlines Receive TYME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tyme Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2021Today5/31/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:TYME CUSIPN/A CIK1537917 Webwww.tymeinc.com Phone(212) 461-2315FaxN/AEmployees17Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-23,630,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-28.30% Return on Assets-26.21% Debt Debt-to-Equity RatioN/A Current Ratio14.06 Quick Ratio14.06 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.47 per share Price / Book0.66Miscellaneous Outstanding Shares172,207,000Free Float143,104,000Market Cap$53.50 million OptionableOptionable Beta0.93 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Richard Cunningham (Age 51)CEO & Director Comp: $789.9kMr. Steven E. Hoffman (Age 59)Co-Founder & Director Comp: $2.6MMr. Frank L. Porfido (Age 58)Chief Financial Officer Comp: $488.2kMr. James Biehl J.D. (Age 58)Chief Legal Officer & Sec. Comp: $635.89kDr. Jonathan M. Eckard (Age 48)Chief Bus. Officer Dr. Jan Marie-Albert Van Tornout M.D. (Age 66)M.Sc., Acting Chief Medical Officer More ExecutivesKey CompetitorsZynerba PharmaceuticalsNASDAQ:ZYNEBioVieNASDAQ:BIVIAytu BioPharmaNASDAQ:AYTUGeneration BioNASDAQ:GBIOPrelude TherapeuticsNASDAQ:PRLDView All Competitors TYME Stock Analysis - Frequently Asked Questions How were Tyme Technologies' earnings last quarter? Tyme Technologies, Inc. (NASDAQ:TYME) issued its quarterly earnings data on Monday, November, 8th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.03. What other stocks do shareholders of Tyme Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tyme Technologies investors own include Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Allena Pharmaceuticals (ALNA), OpGen (OPGN), Selecta Biosciences (SELB), MEI Pharma (MEIP), Pfizer (PFE) and SCYNEXIS (SCYX). This page (NASDAQ:TYME) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyme Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.